학술논문
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
Document Type
article
Author
DAndrea, David; Matin, Surena; Black, Peter; Petros, Firas; Zargar, Homayoun; Dinney, Colin; Cookson, Michael; Kassouf, Wassim; DallEra, Marc; McGrath, John; Wright, Jonathan; Thorpe, Andrew; Morgan, Todd; Holzbeierlein, Jeffrey; Bivalacqua, Trinity; Sridhar, Srikala; North, Scott; Barocas, Daniel; Lotan, Yair; Stephenson, Andrew; van Rhijn, Bas; Spiess, Philippe; Daneshmand, Siamak; Shariat, Shahrokh
Source
BJU International. 127(5)
Subject
Language
Abstract
OBJECTIVE: To assess the differential response to neoadjuvant chemotherapy (NAC) in patients with urothelial carcinoma of the bladder (UCB) compared to upper tract urothelial carcioma (UTUC) treated with radical surgery. PATIENTS AND METHODS: Data from 1299 patients with UCB and 276 with UTUC were obtained from multicentric collaborations. The association of disease location (UCB vs UTUC) with pathological complete response (pCR, defined as a post-treatment pathological stage ypT0N0) and pathological objective response (pOR, defined as ypT0-Ta-Tis-T1N0) after NAC was evaluated using logistic regression analyses. The association with overall (OS) and cancer-specific survival (CSS) was evaluated using Cox regression analyses. RESULTS: A pCR was found in 250 (19.2%) patients with UCB and in 23 (8.3%) with UTUC (P